CONCORD BIOTECH LIMITED

CONCORDBIO

Small Cap | Pharmaceuticals
1327.2
+159 (+13.61%)

Stock price as on 06 Feb 2026 at 15:30 PM

Concord biotech limited share price update

As of the latest trading session, Concord Biotech Limited share price is currently at ₹1327.2, which is up by ₹159 from its previous closing. Today th...

Concord Biotech Limited stock performance

Today’s low

₹1,144.1

Today’s high

₹1,385

₹1,327.2

52 week low

₹1,100

52 week high

₹2,451.7

₹1,327.2
Open
₹1,164.80
Previous close
₹1,168.20
Share volume
38,30,074
Total traded value (Lakh)
₹50,832.74
Upper circuit
₹1,401.80
Lower circuit
₹934.60

Concord Biotech Limited fundamentals

Market cap (Cr)
₹13,884.70
P/E ratio (TTM)
43.58
Book value per share
₹174.47
Beta
0.76
Return on equity
22.35%
Earnings per share (TTM)
₹30.73
Dividend yield
0.65%
Net profit/quarter (Cr)
₹62.90

Concord Biotech Limited financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

₹247.06

Operating expense

₹174.97

Net income

₹62.90

Net profit margin

25.45%

Earning per share

₹6.01

EBITDA

₹103.97

Effective tax rate

26.44%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹203.99

Operating expense

₹160.43

Net income

₹42.57

Net profit margin

20.86%

Earning per share

₹4.07

EBITDA

₹75.08

Effective tax rate

25.62%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹429.88

Operating expense

₹254.18

Net income

₹141.94

Net profit margin

33.01%

Earning per share

₹13.57

EBITDA

₹199.81

Effective tax rate

23.31%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹244.22

Operating expense

₹159.63

Net income

₹74.09

Net profit margin

30.33%

Earning per share

₹7.08

EBITDA

₹112.67

Effective tax rate

25.4%

Particulars

Sep 24 (₹ value in crores)

Revenue

₹310.18

Operating expense

₹186.92

Net income

₹98.70

Net profit margin

31.82%

Earning per share

₹9.43

EBITDA

₹146.70

Effective tax rate

25.95%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹1,200.09

Operating expense

₹748.66

Net income

₹372.96

Net profit margin

31.07%

Earning per share

₹35.65

EBITDA

₹550.78

Effective tax rate

24.78%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹1,016.94

Operating expense

₹641.52

Net income

₹304.73

Net profit margin

29.96%

Earning per share

₹29.13

EBITDA

₹465.33

Effective tax rate

25.52%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹853.17

Operating expense

₹568.42

Net income

₹238.13

Net profit margin

27.91%

Earning per share

₹22.76

EBITDA

₹378.59

Effective tax rate

25.59%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹712.93

Operating expense

₹495.19

Net income

₹178.57

Net profit margin

25.04%

Earning per share

₹187.76

EBITDA

₹296.69

Effective tax rate

25.95%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹616.94

Operating expense

₹317.59

Net income

₹235.33

Net profit margin

38.14%

Earning per share

₹247.40

EBITDA

₹341.36

Effective tax rate

24.85%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹173.27

Return on Equity (ROE)

22.26%

Return on Capital Employed (ROCE)

29.53%

Total debt to equity ratio

-

EBITDA margin

45.83%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹145.93

Return on Equity (ROE)

21.88%

Return on Capital Employed (ROCE)

29.05%

Total debt to equity ratio

0.01

EBITDA margin

46.15%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹123.31

Return on Equity (ROE)

20.06%

Return on Capital Employed (ROCE)

26.27%

Total debt to equity ratio

0.04

EBITDA margin

44.68%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹1,159.99

Return on Equity (ROE)

16.64%

Return on Capital Employed (ROCE)

21.59%

Total debt to equity ratio

0.07

EBITDA margin

41.2%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹1,050.80

Return on Equity (ROE)

26.6%

Return on Capital Employed (ROCE)

32.83%

Total debt to equity ratio

0.08

EBITDA margin

55.42%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹173.27

Return on Equity (ROE)

22.35%

Return on Capital Employed (ROCE)

29.62%

Total debt to equity ratio

-

EBITDA margin

45.94%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹145.80

Return on Equity (ROE)

21.63%

Return on Capital Employed (ROCE)

28.81%

Total debt to equity ratio

0.01

EBITDA margin

45.82%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹123.50

Return on Equity (ROE)

19.85%

Return on Capital Employed (ROCE)

26.05%

Total debt to equity ratio

0.04

EBITDA margin

44.45%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹1,164.13

Return on Equity (ROE)

16.95%

Return on Capital Employed (ROCE)

21.86%

Total debt to equity ratio

0.07

EBITDA margin

41.71%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹1,051.11

Return on Equity (ROE)

26.59%

Return on Capital Employed (ROCE)

32.82%

Total debt to equity ratio

0.08

EBITDA margin

55.39%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹1.18

Total assets

₹2,034.25

Total liabilities

₹2,034.25

Total equity

₹1,812.71

Shares outstanding

₹10.46

Price to book ratio

₹9.67

Return on assets (%)

18.26%

Return on capital

20.5%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹47.02

Total assets

₹1,700.70

Total liabilities

₹1,700.70

Total equity

₹1,526.64

Shares outstanding

₹10.46

Price to book ratio

₹10.44

Return on assets (%)

18.11%

Return on capital

20.1%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹43.44

Total assets

₹1,513.98

Total liabilities

₹1,513.98

Total equity

₹1,290.00

Shares outstanding

₹10.46

Price to book ratio

-

Return on assets (%)

15.85%

Return on capital

18.17%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹88.93

Total assets

₹1,312.79

Total liabilities

₹1,312.79

Total equity

₹1,103.22

Shares outstanding

₹0.95

Price to book ratio

-

Return on assets (%)

13.32%

Return on capital

15.03%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹60.81

Total assets

₹1,182.54

Total liabilities

₹1,182.54

Total equity

₹999.37

Shares outstanding

₹0.95

Price to book ratio

-

Return on assets (%)

19.9%

Return on capital

22.19%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹1.18

Total assets

₹2,034.18

Total liabilities

₹2,034.18

Total equity

₹1,812.64

Shares outstanding

₹10.46

Price to book ratio

₹9.67

Return on assets (%)

18.33%

Return on capital

20.57%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹47.02

Total assets

₹1,699.31

Total liabilities

₹1,699.31

Total equity

₹1,525.25

Shares outstanding

₹10.46

Price to book ratio

₹10.44

Return on assets (%)

17.93%

Return on capital

19.9%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹43.44

Total assets

₹1,514.64

Total liabilities

₹1,514.64

Total equity

₹1,291.98

Shares outstanding

₹10.46

Price to book ratio

-

Return on assets (%)

15.72%

Return on capital

18%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹88.93

Total assets

₹1,313.45

Total liabilities

₹1,313.45

Total equity

₹1,107.16

Shares outstanding

₹0.95

Price to book ratio

-

Return on assets (%)

13.59%

Return on capital

15.29%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹60.81

Total assets

₹1,182.84

Total liabilities

₹1,182.84

Total equity

₹999.67

Shares outstanding

₹0.95

Price to book ratio

-

Return on assets (%)

19.89%

Return on capital

21.67%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹494.55

Cash from operations

₹353.93

Cash from investing

-₹159.98

Cash from financing

-₹98.76

Net change in cash

-₹14.23

Free cash flow

₹465.10

Particulars

Mar 24 (₹ value in crores)

Net income

₹412.56

Cash from operations

₹368.81

Cash from investing

-₹154.60

Cash from financing

-₹99.21

Net change in cash

₹11.64

Free cash flow

₹454.50

Particulars

Mar 23 (₹ value in crores)

Net income

₹322.01

Cash from operations

₹316.27

Cash from investing

-₹157.95

Cash from financing

-₹85.21

Net change in cash

₹2.83

Free cash flow

₹461.36

Particulars

Mar 22 (₹ value in crores)

Net income

₹237.51

Cash from operations

₹268.25

Cash from investing

-₹111.78

Cash from financing

-₹100.16

Net change in cash

-₹4.47

Free cash flow

₹423.76

Particulars

Mar 20 (₹ value in crores)

Net income

₹213.63

Cash from operations

₹204.19

Cash from investing

-₹113.92

Cash from financing

-₹42.51

Net change in cash

-₹1.35

Free cash flow

₹204.19

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹495.87

Cash from operations

₹353.93

Cash from investing

-₹159.98

Cash from financing

-₹98.76

Net change in cash

-₹14.23

Free cash flow

₹465.10

Particulars

Mar 24 (₹ value in crores)

Net income

₹409.19

Cash from operations

₹368.81

Cash from investing

-₹154.60

Cash from financing

-₹99.21

Net change in cash

₹11.64

Free cash flow

₹454.50

Particulars

Mar 23 (₹ value in crores)

Net income

₹320.05

Cash from operations

₹316.27

Cash from investing

-₹157.95

Cash from financing

-₹85.21

Net change in cash

₹2.83

Free cash flow

₹461.36

Particulars

Mar 22 (₹ value in crores)

Net income

₹241.15

Cash from operations

₹268.25

Cash from investing

-₹111.78

Cash from financing

-₹100.16

Net change in cash

-₹4.47

Free cash flow

₹423.76

Particulars

Mar 21 (₹ value in crores)

Net income

₹313.16

Cash from operations

₹241.98

Cash from investing

-₹195.20

Cash from financing

₹31.12

Net change in cash

₹2.73

Free cash flow

₹446.16

Concord Biotech Limited technical summary

₹1327.2
+ 13.61 ▲
12
Bearish
4
Bullish
5 Day1,220.1
10 Day1,211.6
12 Day1,215.3
20 Day1,237
26 Day1,253.2
50 Day1,310.2
100 Day1,408.6
200 Day1,523.8
5 Day1,189.7
10 Day1,186.8
12 Day1,198.2
20 Day1,244.2
26 Day1,266.9
50 Day1,317.6
100 Day1,422.1
200 Day1,574.9

1164.83

PIVOT

First support
₹0.00
First resistance
₹0.00
Second support
₹0.00
Second resistance
₹0.00
Third support
₹0.00
Third resistance
₹0.00
RSI
58.55
ADX
28.76
MACD
-37.9
Williams % R
-20.28
Commodity Channel Index (CCI)
44.24
Date
06 Feb 2026
Same day
1,61,017
Week
61,927
Month
43,752
1 year
0.76
3 years
0.65
Over 1 month
-1.84%
Over 1 year
-43.33%
Over 3 months
-5.96%
Over 3 years
12.07%
Over 6 months
-19.72%
Over 6 years
0%

Investment Returns

Over 1 Month1.84%
Over 3 Months5.96%
Over 6 Months19.72%
Over 1 Year43.33%

Concord Biotech Limited Shareholding pattern


Public
38.75%
Promoter holdings
44.08%
FII
7.57%
DII
9.58%
Promoter shares
0%
Promoter sharesShareCategory

Sudhir Kumar Vaid

3,01,69,524 (28.84%)

Shareholding of Promoter and Promoter Group

Manju Vaid

99,87,636 (9.55%)

Shareholding of Promoter and Promoter Group

Aryavir Jhunjhunwala Discretionary Trust

83,99,754 (8.03%)

Public Shareholding

Nishtha Jhunjhunwaladiscretionary Trust

83,99,732 (8.03%)

Public Shareholding

Aryaman Jhunjhunwaladiscretionary Trust

83,99,754 (8.03%)

Public Shareholding

Promoter sharesShareCategory
Sudhir Kumar Vaid3,01,69,524 (28.84%)Shareholding of Promoter and Promoter Group
Manju Vaid99,87,636 (9.55%)Shareholding of Promoter and Promoter Group
Aryavir Jhunjhunwala Discretionary Trust83,99,754 (8.03%)Public Shareholding
Nishtha Jhunjhunwaladiscretionary Trust83,99,732 (8.03%)Public Shareholding
Aryaman Jhunjhunwaladiscretionary Trust83,99,754 (8.03%)Public Shareholding
Sudman Consultants Llp47,52,000 (4.54%)Shareholding of Promoter and Promoter Group
Government Pension Fund Global31,28,149 (2.99%)Public Shareholding
Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap Fund21,11,372 (2.02%)Public Shareholding
1575773 Ontario Inc20,92,325 (2%)Public Shareholding
Amal Parikh18,23,219 (1.74%)Public Shareholding
Dsp Small Cap Fund18,21,727 (1.74%)Public Shareholding
Axis Max Life Insurance Limited A/c Reversionary Bonus Participating - Equity15,84,988 (1.52%)Public Shareholding
Ravindra Raichand Dharamshi12,56,432 (1.2%)Public Shareholding
Chanakya Corporate Services Pvt Ltd11,63,833 (1.11%)Public Shareholding
Ankur Sudhir Vaid5,86,520 (0.56%)Shareholding of Promoter and Promoter Group
Vaid Megha Ankur5,47,008 (0.52%)Shareholding of Promoter and Promoter Group
Sonal Kumra73,920 (0.07%)Shareholding of Promoter and Promoter Group

About CONCORD BIOTECH LIMITED

Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation

Parent Organisation

Indian Private

NSE Symbol

CONCORDBIO

Founded

1984

CONCORD BIOTECH LIMITED CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
03 Sept 202510.7Final03 Sept 2025Equity shares
21 Jun 20248.75Final22 Jun 2024Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)